Morgan Stanley PE Asia has acquired a controlling stake in ClearMedi Healthcare, a Delhi-based oncology hospital and radiation therapy centre chain, for approximately $35 million (Rs 285 crore).

According to people briefed on the transactions, Italy's KOS Group exited ClearMedi by selling its stake to the PE firm and the healthcare provider's promoters.

According to the sources, the transaction also included an equity investment in the company. They did not reveal specifics, such as the proportion of stakes chosen by the PE fund and the KOS Group founders, or the amount of money invested in the company.

Founded in 2010 by Shashi Kant Baliyan, ClearMedi runs its facilities in eight states and a union territory.

Chennai-based investment bankers Advay Capital advised the promoter team of Clearmedi and Morgan Stanley PE on the transaction.